American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

被引：1078

作者：

Saag, Kenneth G. ^{[2
]}

Teng, Gim Gee ^{[2
]}

Patkar, Nivedita M. ^{[2
]}

Anuntiyo, Jeremy ^{[1
]}

Finney, Catherine ^{[1
,6
]}

Curtis, Jeffrey R. ^{[2
]}

Paulus, Harold E. ^{[1
]}

Mudano, Amy ^{[2
]}

Pisu, Maria ^{[2
]}

Elkins-Melton, Mary ^{[2
]}

Outman, Ryan ^{[2
]}

Allison, Jeroan J. ^{[2
]}

Almazor, Maria Suarez ^{[3
]}

Bridges, S. Louis, Jr. ^{[2
]}

Chatham, W. Winn ^{[2
]}

Hochberg, Marc ^{[4
]}

Maclean, Catherine ^{[1
,5
]}

Mikuls, Ted ^{[7
]}

Moreland, Larry W. ^{[8
]}

O'Dell, James ^{[1
,5
,6
]}

Turkiewicz, Anthony M. ^{[2
]}

Furst, Daniel E. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA 90095 USA

[2] Univ Alabama, Tuscaloosa, AL 35487 USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Univ Maryland, Baltimore, MD 21201 USA

[5] RAND Corp, Santa Monica, CA USA

[6] W Los Angeles VAMC, Los Angeles, CA USA

[7] Univ Nebraska, Omaha, NE 68182 USA

[8] Univ Pittsburgh, Pittsburgh, PA USA

来源：

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2008年 / 59卷 / 06期

关键词：

D O I：

10.1002/art.23721

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.

引用

页码：762 / 784

页数：23

共 265 条

[1] Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA
Agrawal, Sumeet
Misra, Ramnath
Aggarwal, Amita
[J]. CLINICAL RHEUMATOLOGY, 2007, 26 (02) : 201 - 204
[2] *AGREE COLL, 2001, INTR AGREE COLL
[3] The definition and measurement of disease modification in inflammatory rheumatic diseases
Aletaha, D
Smolen, JS
[J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2006, 32 (01) : 9 - +
[4] Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states
Aletaha, D
Ward, MM
Machold, KP
Nell, VPK
Stamm, T
Smolen, JS
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2625 - 2636
[5] TREATMENT OF FELTYS SYNDROME WITH LOW-DOSE ORAL METHOTREXATE
ALLEN, LS
GROFF, G
[J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (07): : 902 - 905
[6] Testing for hepatitis C virus infection should be routine for persons at increased risk for infection
Alter, MJ
Seeff, LB
Bacon, BR
Thomas, DL
Rigsby, MO
Di Bisceglie, AM
[J]. ANNALS OF INTERNAL MEDICINE, 2004, 141 (09) : 715 - 717
[7] Andersen LS, 1997, J RHEUMATOL, V24, P830
[8] [Anonymous], 1994, NOMENCLATURE CRITERI, V9th, P253
[9] [Anonymous], MMWR MORB MORTAL WKL
[10] ARNOLD MH, 1990, BRIT J RHEUMATOL, V29, P120

← 1 2 3 4 5 6 7 8 9 10 →